Nanexa AB

Nanexa AB is a drug-delivery biotech, and by our assessment that makes it most relevant to people who care about how medicines are formulated rather than about a single headline molecule. Its strength is the delivery side itself: controlled release and formulation work can make existing drugs more practical, not just new ones more ambitious. The downside is the usual biotech one, but in a very specific form here — technical promise has to survive development, regulation, and real-world manufacturing before it becomes a product. In practice Nanexa AB is the kind of company where the science matters first and the commercial story comes later, which is why it feels more specialized than a broad pharma name. It sits in the small but serious corner of biotech that works on how a drug gets into the body, not just on what the drug is.